Literature DB >> 3578454

Pathogenesis of osteoporosis.

B L Riggs.   

Abstract

Five major risk factors for osteoporosis have been identified: age, initial bone density, the menopause, bioavailability of calcium, and sporadic factors. Age appears to be the major determinant of bone mass. During a lifetime, a woman will typically lose 50% of her trabecular bone and 35% of her cortical bone. Bone density is affected by the amount of bone developed during growth, as well as by the subsequent rate of loss. Strong evidence has shown that loss of ovarian function leads to an accelerated phase of bone loss. Bone turnover rates increase, but resorption occurs faster than formation. This acceleration slows with time, reaching the level of the underlying slower phase of bone loss approximately 10 years after the onset of menopause. The role of calcium intake in preventing osteoporosis remains a matter of debate. Other factors shown to affect the risk of osteoporosis include low weight, smoking, alcohol intake, and degree of physical activity. The fact that not all postmenopausal women develop osteoporosis suggests that other, as-yet-undetermined factors may play a role in this condition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3578454     DOI: 10.1016/0002-9378(87)90176-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Effects of Lemon Beverage Containing Citric Acid with Calcium Supplementation on Bone Metabolism and Mineral Density in Postmenopausal Women: Double-Blind 11-Month Intervention Study.

Authors:  Hiromi Ikeda; Tadayuki Iida; Masanori Hiramitsu; Takashi Inoue; Satomi Aoi; Miho Kanazashi; Fumiko Ishizaki; Toshihide Harada
Journal:  J Nutr Metab       Date:  2021-02-24

2.  The effect of previous oral contraceptive use on bone mineral density in perimenopausal women.

Authors:  M Tuppurainen; H Kröger; S Saarikoski; R Honkanen; E Alhava
Journal:  Osteoporos Int       Date:  1994-03       Impact factor: 4.507

3.  Effect of lactoferrin on osteogenic differentiation of human adipose stem cells.

Authors:  Xiaozhou Ying; Shaowen Cheng; Wei Wang; Zhongqin Lin; Qingyu Chen; Wei Zhang; Dongquan Kou; Yue Shen; Xiaojie Cheng; Lei Peng; Hua Zi Xu; Chuan Zhu Lu
Journal:  Int Orthop       Date:  2011-06-29       Impact factor: 3.075

4.  Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.

Authors:  C de la Piedra; R Torres; A Rapado; M Diaz Curiel; N Castro
Journal:  Calcif Tissue Int       Date:  1989-07       Impact factor: 4.333

5.  Effects of androgens on subpopulations of the human osteosarcoma cell line SaOS2.

Authors:  C H Kasperk; K Faehling; I Börcsök; R Ziegler
Journal:  Calcif Tissue Int       Date:  1996-05       Impact factor: 4.333

6.  Overweight postmenopausal women lose bone with moderate weight reduction and 1 g/day calcium intake.

Authors:  Claudia S Riedt; Mariana Cifuentes; Theodore Stahl; Hasina A Chowdhury; Yvette Schlussel; Sue A Shapses
Journal:  J Bone Miner Res       Date:  2004-11-29       Impact factor: 6.741

7.  Cadmium accelerates bone loss in ovariectomized mice and fetal rat limb bones in culture.

Authors:  M H Bhattacharyya; B D Whelton; P H Stern; D P Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Ability of different techniques of measuring bone mass to determine vertebral bone loss in aging female rats.

Authors:  M Safadi; D Shapira; I Leichter; A Reznick; M Silbermann
Journal:  Calcif Tissue Int       Date:  1988-06       Impact factor: 4.333

9.  Effect of ipriflavone and estrogen on the differentiation and proliferation of osteogenic cells.

Authors:  Y Kakai; T Kawase; T Nakano; Y Mikuni-Takagaki; S Saito
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

10.  Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice.

Authors:  Tadashi Goto; Keitaro Hagiwara; Nobuaki Shirai; Kaoru Yoshida; Hiromi Hagiwara
Journal:  Cytotechnology       Date:  2014-02-06       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.